Intravenous beta-blocker therapy in ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention is not associated with benefit regarding short-term mortality: a Swedish nationwide observational study. [electronic resource]
Producer: 20180319Description: e210-e218 p. digitalISSN:- 1969-6213
- Administration, Intravenous
- Adrenergic beta-Antagonists -- administration & dosage
- Aged
- Female
- Hospital Mortality
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Multivariate Analysis
- Odds Ratio
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Propensity Score
- Registries
- Risk Factors
- ST Elevation Myocardial Infarction -- diagnosis
- Shock, Cardiogenic -- etiology
- Stroke Volume -- drug effects
- Sweden
- Time Factors
- Treatment Outcome
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Journal Article; Observational Study
There are no comments on this title.
Log in to your account to post a comment.